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Objective. Assessing the level of anxiety in oncology patients who underwent 18F-FDG PET/CT low dose scan and identifying the
main reasons that generate anxiety.Material andMethod. The study included 81 cancer patients submitted to the 18F-FDG PET/CT
low dose scan. Patients filled in the Scan Experience Questionnaire and the State-Trait Anxiety Inventory (STAI) before and after
18F-FDG PET/CT low dose scan. Results. Substantial levels of anxiety were detected both before and after 18F-FDG PET/CT low
dose scan (STAI mean > 30), with a significant increase in the state of anxiety after scan performance (𝑝 < 0.0001, Medianpre = 31.1,
and Medianpos = 33.0).
18F-FDG PET/CT low dose results are the main cause of anxiety both before (79.1%) and after (86.9%) the
scan. The information provided by staff both before and on the 18F-FDG PET/CT low dose day was classified mostly as completely
understandable (70.5% and 75.3%, resp.) and as very useful (70.5% and 72.6%, resp.) and correlated positively with patients’ overall
satisfaction with NM Department (𝑟𝑆 = 0.372, 𝑝 = 0.004 and 𝑟𝑆 = 0.528, p = 0.000, resp.), but not with anxiety levels. Conclusions.
Patients perceive high levels of anxiety during the 18F-FDG PET/CT low dose scan and the concern with scan results was pointed
out as the main factor for that emotional reaction.
1. Introduction
Positron Emission Tomography/Computed Tomography
(PET/CT) low dose with 18F-fluor-2-deoxi-D-glucose (18F-
FDG) and other radiopharmaceuticals (e.g., 11C-colina, 11C-
acetato, and 11C-metionina) is of increasing interest in the
study of the cancer patient since it is indicated in differential
diagnosis, follow-up, and prognostic and therapeutic plan
related to cancer diseases [1, 2].
Anxiety can be defined as a complex reaction to situations
when perceived by patient as dangerous even if just under
an uncertain circumstance. It can take many forms, as
psychic, physiological, and behavioral components [3]. This
emotional reaction is often felt by cancer patients during
18F-FDG PET/CT low dose scans. There are many factors
that can generate anxiety during 18F-FDG PET/CT low
dose procedures, as the use of radiopharmaceuticals, which
produce radiation and because of it many patients can
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experience anxiety [4]. The equipment is a source of great
anxiety in claustrophobic patients. Anxiety is also related to
what the scan represents to the patient not only because of the
procedure itself but also due to the results of the scanning and
what it can represent to him or her, especially in a situation
of oncology disease diagnostic or recrudescence of a cancer
previously diagnosed [5]. Patients with hearing problems
and difficulty in speaking may experience higher levels of
anxiety because of the limited communication between them
and health professionals [5, 6] (i.e., nurses, technologists of
nuclear medicine, and physicians). High levels of anxiety can
result in a poor image quality due to patientmovement during
procedure, which increases the uptake in the brown adipose
tissue and in the muscle, leading to image false-positives [5,
7–9]. For that reason, the patient must rest after the injection
of the radiopharmaceutical allowing the muscles to relax
[9].
18F-FDG PET/CT low dose scan is prolonged and
involves transmission of lots of information to the patient
about radiopharmaceutical, scan procedure, between 30-
and 60-minute waiting times. Therefore, effective com-
munication is important because it allows the seizure
and understanding of such information [5]. Some studies
show that informed consent, including brief information
about the risk factors and potential adverse reactions of
the exam, reduces the level of anxiety, whereas detailed
information before the procedure increases the anxiety
level [10]. This fact is independent of the sociocultural
level of the individual since a highly literate patient may
also have difficulty in interpreting medical information
[10].
The provision of adequate information should take
the patient’s needs into account, thus contributing to the
increase of compliance, the reduction of symptoms, such
as anxiety and fear, and the increase of customer satis-
faction [11, 12]. The feeling of dissatisfaction means that
the patient does not verbalize his or her concerns and his
or her vulnerability and feels less relaxed. The assessment
of patient satisfaction is difficult to quantify or even to
define [13]. So all along health professionals should remind
them of relevant information and clarify any doubts to the
patient to make sure he or she is still, does not move,
and is safe during the following examination, in anamnesis
[14].
However research pointed out a few causes of anxiety;
little evidence is currently available regarding the impact
of information and the satisfaction with Nuclear Medicine
Department on the levels of anxiety of patients when
going through 18F-FDG PET/CT low dose scan. By provid-
ing detailed understanding of the levels of anxiety during
18F-FDG PET/CT low dose scan, educational efforts can
be focused towards reducing anxiety related to 18F-FDG
PET/CT low dose which could potentially interfere with
patients’ satisfaction and diagnostic accuracy. Therefore, this
study aims to evaluate the level of anxiety in cancer patients
who underwent PET/CT low dose scan with 18F-FDG and
identify the main reasons that generate anxiety among these
patients.
2. Material and Methods
2.1. Design. A cross-sectional prospective study was per-
formed in two separateNuclearMedicine (NM)Departments
in the Iberian Peninsula, between 1st of April and 31st of
May 2015, in cancer patients of different types (lung, breast,
prostatic, and lymphoma) with clinical indication to do the
18F-FDG PET/CT low dose scan.
2.2. Participants and Settings. First authorization was
requested from the boards of the two NM Departments. All
eligible patients were previously notified with the purpose
of the study, the protection of their personal information,
the voluntary nature of participation, and the possibility
to withdraw from the study at any time. Data collection
commenced once the patient’s written informed consent was
obtained.
The convenience sample consisted of 95 patients who
were scheduled for 18F-FDG PET/CT low dose. All patients
complied with the inclusion following criteria: (1) over 18
years and (2) clinical indication for oncology reasons (lung,
breast, prostatic, and lymphoma) to conduct the studies
of 18F-FDG PET/CT low dose. Exclusion criteria included
(1) patients with significant communication disabilities that
would affect their ability to respond to questionnaires, (2)
patients with a history of psychiatric illness, (3) patients
in poor condition who were unable to cooperate, and (4)
patients who scored more than 45 in State-Trait Anxiety
Inventory survey (STAI-S) (see below for more details of
these criteria).
Of all patients initially recruited 14 were excluded because
they answered less than 80% in any of the questionnaires.
With regard to STAI-T outcomes no patient was excluded
because none scored above 3rd quartile; that is, all are below
the value 45. Therefore, the study included 81 cancer patients
submitted by clinical indication to the 18F-FDG PET/CT low
dose scan.
2.3. Measurements
2.3.1. Scan Experience Questionnaires (SEQ). With the pur-
pose of evaluatingwhich variables are related to the anxiety of
patients we used two Scan Experience Questionnaires (SEQ):
Pre and Post Scan (see “Appendix”). The questions of each
questionnaire were based on a Portuguese larger survey used
in 232 patients who underwent PET/CT [15]. We only used
questions relevant to the purpose of this study. The SEQ
Pre Scan offers information about the following domains
(Table 1): demographic and clinical details about the patient,
major patients’ concerns, and information offered the day
before 18F-FDG PET/CT low dose scan.
The SEQ Post Scan affords information in four domains
(Table 1): concerns, patient’s experience during the proce-
dure, patient’s evaluation of the information provided by
the professionals prior to the scan, and patient’s overall
satisfaction about the department.
Patient answered each item of the domain Information
on the day before 18F-FDG PET/CT low dose scan on SEQ
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Table 1: Domains of the Scan Questionnaire Experience (SQE) questionnaires: before and after procedure.
Questionnaire Domains Question number
Pre Scan
Demographic and clinical 1, 2, 3, 4, 5, 6
Concerns 7
Information on the day before 18F-FDG PET/CT low dose scan 8.1, 8.2
Post Scan
Concerns 1
Scan Experience 2, 3
Information on 18F-FDG PET/CT low dose scan day 4.1, 4.2, 5
Department 6, 7
Pre Scan and the domains of Scan Experience, Information
on 18F-FDG PET/CT low dose day, and Department on SEQ
Post Scan in a Likert scale. Higher values indicated a more
positive assessment. The questions related to demography,
clinical domain (SEQ Pre Scan), and concerns (SEQ Pre and
Post Scan) included various possible answers.
Cronbach’s Alpha coefficients were used in order to eval-
uate the extent to which the questions of the subscales of the
SEQ measure the same concept. The following results were
verified: 0.794 to the domain of Information on the day before
18F-FDG PET/CT low dose scan, 0.711 to the perception
of the scan achievement, 0.643 to the evaluation of the
information during the scan, and 0.660 to the perception of
overall satisfaction of the department. Cronbach’s Alpha val-
ues obtained showed reasonable internal consistency (0.8 >
𝛼 ≥ 0.7) except for the domains related to the evaluation
of the information during the scan and to the perception of
overall satisfaction of the department where the values are
questionable (0.7 > 𝛼 ≥ 0.6). These results could be due to
the low number of questions in these domains [16].
2.3.2. Spielberger State-Trait Anxiety Inventory (STAI). To
assess the anxiety degree we used Spielberger STAI [17],
a standardized psychologic evaluation already adapted into
Spanish [18] and Portuguese [19].
The STAI is one of the best-established anxiety measures
[8, 17, 19], having been used in many studies in several fields
of health research. State anxiety (STAI-S) evaluates how the
patient feels in that particular situation or moment (e.g., I
feel calm; I am angry; I feel very under pressure) and it
reflects how threatening a person perceives his environment
while in it. The trait anxiety (STAI-T) evaluates how patients
“generally feel” (i.e., “I am a steady person”; “I lack self-
confidence”) [17]. Participants are asked to rate themselves on
each item on the basis of a 4-point Likert scale, ranging from
not at all (0) to very much so (4) for the STAI-S and from
almost never to almost always for the STAI-T. At the end the
scores obtained in each test range from 0 to 60, higher values
indicate increased anxiety level, while lower scores indicate
decreased anxiety level.There is no cut-off value in these tests.
The descriptive statistics was used as a standard measure
in order to evaluate STAI-S questionnaires, where the overall
assessment is obtained through the sum of items, ranging
between 0 and 60 points. The cut-off point for the exclusion
of some patients was the third quartile of the scale, that is, the
value 45.
2.4. Procedure. On the day before the scan, two NMDepart-
ments in the Iberian Peninsula gave all patients oral infor-
mation related to medication, exercise, fasting, and length of
time they would need as far as 18F-FDG PET/CT low dose
was concerned.
On the exam day, all selected cancer patients were
contacted by one of researchers who informed patients about
the study and gave them an informed consent form to let
them know about the study procedures.
The patients filled the SEQ Pre Scan, STAI-S, and STAI-
T forms in a separate room, before radiopharmaceutical
injection to conduct the 18F-FDG PET/CT low dose scan.
Later, oral procedural and sensory information was given.
Procedural information includes the need to inject a very
small amount of radiopharmaceuticals and to rest quietly
after the injection and scan procedures: positioning, immobi-
lization, andduration of scan. Sensory information comprises
the need to have a cannula into one of the veins in the back
of hand or arm, to stay alone in the scanning room, and to lie
on his or her back on a narrow bed. Patients were told that
the bed moves through the scanner and they would be given
a blanket in order to be comfortable.
After collecting data in 18F-FDG PET/CT low dose scan,
all patients completed the SEQ Post Scan and STAI-S. Only
questionnaires in whichmore than 80% of the questions were
answered by the patients were included in this study [19].
2.5. Statistical Analyses. Data analyses were carried out using
the Statistical Packages for the Social Science, SPSS, version
22.0 for Windows. Descriptive analyses of the study sample
were performed. The Shapiro-Wilk test was used with the
objective of assessing the normality of data. Results are
considered significant at the 5% significance level (𝑝 < 0.05).
Mann–Whitney U test was used to compare the state
of anxiety between patients who perform the scan for the
first time and those who had already performed previ-
ously the scan and between genders. Kruskal-Wallis test
was used to compare anxiety among education levels and
among the reasons that lead to the examination. Spearman
correlation coefficient was used to evaluate the correlation
between anxiety (before and after scan) and the various
domains of SEQ. Wilcoxon test was used to compare
STAIT-S before and after scan. Because normality assump-
tion was not verified (𝑝 < 0.05) and, moreover, has
detected the presence of outliers, nonparametric statistic was
used.
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Reason for anxiety 67 (82.7%) 61 (75.3%)
Scan procedure 8 (11.9) 4 (6.6)
Results 53 (79.1) 53 (86.9)
Illness 2 (3.0) 1 (1.6)
Other 4 (6.0) 3 (4.9)
Information understanding 61 (75.3) 73 (90.1)
More or less understandable 3 (4.9) 4 (5.5)
Understandable 15 (24.6) 14 (19.2)
Completely understandable 43 (70.5) 55 (75.3)
Utility of the information 61 (75.3) 73 (90.1)
Not very useless 1 (1.6) 0.0
More or less useful 2 (3.3) 2 (2.7)
Useful 15 (24.6) 18 (24.7)
Very useful 43 (70.5) 53 (72.6)
Comfortability to ask questions 77 (95.1)
No, never — 1 (1.3)
Yes, few times — 2 (2.6)
Yes, sometimes — 3 (3.9)
Yes, almost of times — 17 (22.1)
Yes, always — 54 (70.1)
Response to questions/doubts 77 (95.1)
Hardly adequate — 1 (1.3)
More or less adequate — 8 (10.4)
Adequate — 28 (36.4)
Very adequate — 40 (51.9)
Need more information? 77 (95.1)
Yes — 4 (5.2)
No — 73 (94.8)
Treatment with dignity and respect 77 (95.1)
Almost — 8 (10.4)
Always — 69 (89.6)
Satisfaction with department 77 (95.1)
Not very satisfied — 1 (1.3)
Satisfied — 10 (13.0)
Very satisfied — 66 (85.7)
SEQ: Scan Experience Questionnaire.
3. Results
Out of the 81 cancer patients included in the study, 43 (53.1%)
were female and 38 (46.9%) were male, with a mean age of 55
± 14 years (range, 18–79 years). As regards education levels,
17 (20.9%) have compulsory education, 10 (12.3%) secondary
education, 23 (28.3%) bachelor’s degree, and 31 (38.3%) other
levels of education. 77 (95.1%) of the patients knew the reason
of the exam. 31 (38.3%) of the patients were made to restage
the clinical condition, 22 (27.2%) to initial staging, 20 (24.6%)
to assess response to treatment, and 8 (9.8%) to exclude
cancer recurrence. 38 (46.9%) carried out the exam for the
first time.
According to Table 2, for the majority of patients, 18F-
FDG PET/CT low dose results are the main cause of anxiety
either before or after the scan. Most patients consider that the
information provided on the phone on the day before the 18F-
FDG PET/CT low dose appointment and during the scan in
the NM Department was completely understandable (70.5%
and 75.3%, resp.) and very useful (70.5% and 72.6%, resp.).
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Table 3: Comparison of STAI-S before and after scan.
STAI-S Mean SD Median Test statistics
a
𝑧 𝑝
Before scan 31.099 5.16 31.1
−4.172 0.000
After scan 33.91 4.19 33.0
STAI-S: Spielberger State-Trait Anxiety Inventory.
aWilcoxon signed-ranks test: 𝑝 < 0.005.
About 85.7% of the evaluated patients proved extremely
pleased with the service and 89.6% felt treated with dignity
and respect.
When one variable moves higher or lower, the other vari-
able moves in the same direction with the same magnitude.
The following significant correlations with low intensity
(𝑝 < 0.05) and positive direction were detected: STAI-S Pre
Scan and STAI-S Post Scan (𝑟𝑆 = 0.280, 𝑝 = 0.011); STAI-S
Post Scan and the domain of Scan Experience (𝑟𝑆 = 0.266,
𝑝 = 0.022); the domain Information on the day before 18F-
FDG PET/CT low dose and the domain Information on 18F-
FDG PET/CT low dose scan day (𝑟𝑆 = 0.373, 𝑝 = 0.006);
the domain Information on the day before 18F-FDG PET/CT
low dose and the domain Overall Satisfaction of Department
(𝑟𝑆 = 0.372, 𝑝 = 0.004); the domain Scan Experience and the
domain Information on 18F-FDG PET/CT low dose scan day
(𝑟𝑆 = 0.397, 𝑝 = 0.001); the domain Scan Experience and
the domain Overall Satisfaction of Department (𝑟𝑆 = 0.239,
𝑝 = 0.040); the domain Overall Satisfaction of Department
and the domain Information on 18F-FDG PET/CT low dose
scan day (𝑟𝑆 = 0.528, 𝑝 = 0.000). As significant correlations
were obtained in the positive direction these results indicate
that higher values in one of the variables are related to high
values of the other.
Statistically significant differences of anxiety between
genders (𝑝 > 0.05) and between patients who carried out the
scan for the first time and those who had already previously
performed the scan (𝑝 > 0.05) were not detected (before and
after scan). Statistically significant differences in the state of
anxiety among the various levels of education (𝑝 > 0.05) or
among the reasons that led to the scan (𝑝 > 0.05) were also
not detected.
As far as patient age and anxiety are concerned, there
were not identifiable significant correlations between ages
and STAI-S before (𝑟𝑆 = 0.025, 𝑝 = 0.709) and after (𝑟𝑆 =
0.046, 𝑝 = 0.484) scan.
Table 3 shows the descriptive measures of the STAI-S and
reports statistically significant differences in STAI-S before
and after scan (𝑝 < 0.0001), verifying that STAI-S scores at
Post Scan are significantly higher than STAI-S scores at Pre
Scan.
4. Discussion
Anxiety is a common form of distress that people who suffer
from an oncology disease are likely to experience. However,
there are few published evidences specifically related to the
experience of anxiety among patients in imaging studies [20].
The purpose of this study was to research cancer patients’
anxiety regarding 18F-FDG PET/CT low dose examination
and to explore the main reasons that generate anxiety among
these patients.
Great levels of anxiety were detected both before and
after 18F-FDG PET/CT low dose performance (STAI mean >
30). No statistically significant differences were found in the
association between the social-demographic variables (i.e.,
gender, age, and level of education), the reason for the test,
and the state anxiety levels before and after the scan. Other
studies [15, 20] found great anxiety in male patients who
went through 18F-FDG PET/CT low dose during the initial
staging or during the evaluation of the recurrence of a tumor.
The number of patients in our study could account for these
differences; however, further researches with larger samples
are needed in the future.
The first aim of anxiety management should be to assess
the nature and controllability of anxiety faced by patients. In
our study, the main reason, for more than two thirds of all
patients predisposed to the experience of anxiety, was related
to concerns with the result coming from scanning, and,
consequently, an uncontrollable matter. Comparable results
had been shownbyAbreu et al. [15]with oncology outpatients
performing 18F-FDG PET/CT low dose scan and also by
Dome`nech et al. [3], with patients receiving radioiodine
treatment or undergoing a sentinel lymph node in the NM
Department. Another study in an imaging department of
a cancer center, by Ollivier et al. [21], also found that the
most frequent reason for being worried was anxiety about the
results.
The patients’ concern with 18F-FDG PET/CT low dose
results may well explain why there were not significant
differences in the state of anxiety among patients who went
through scanning for the first time and those who had
undergone it previously. These findings pointed out that
the experience of 18F-FDG PET/CT low dose does not
minimize its emotional impact in cancer patients. Previous
research has showed that repeated experience with Magnetic
Resonance Imaging (MRI) simulated decrease in the levels
of anxiety in claustrophobic patients’ [22]. However, in
our study, this does not happen with most patients who
had previously been through one scan. Literature suggests
[23] that this experience is not enough to differentiate
these patients from others who undergo the exam for the
first time. Clinical conditions can also account for these
results. In fact, cancer patients often experience emotional
distress, including anxiety [24] and, particularly, medical
imaging can be pointed out by cancer patients as a threat
[20].
Contrary to findings from previous studies [15], in our
study the levels of anxietywere higher after the 18F-FDGPET/
CT low dose scan. This increase in the state of anxiety could
be related to the anticipation of the results, since patients are
aware that the outcome of the examination can determine
the severity of the disease (in the case of initial staging or
restaging clinical condition), the efficacy of treatment (e.g.,
chemotherapy and radiotherapy), or the recurrence of cancer.
This recognition suggests that the uncertainty of scan results
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has great influence on the patients’ experience of anxiety [23].
Alternatively, these levels could show the feeling of insecurity
[23] or exhaustion and discomfort after an intensive period
on a rigid body position, especially with the arms positioned
over the head, in a restricted space [11, 25, 26]. It remains to
be determined whether these anxiety levels increased after
patients leave the uptake room or anxiety increases during
image acquisition. Because anxiety levels had the potential to
cause motion artifacts, the quality of 18F-FDG PET/CT low
dose and the accuracy of diagnostic decision making can be
affected [5, 8]. Future work is required to deepen this topic,
for example, by the introduction of physiological measures
during the image acquisition of the 18F-FDG PET/CT low
dose [3].
The information provided, either on the phone on the
day before the examination or on the 18F-FDG PET/CT
low dose day in the NM Department, was classified
mostly as totally understandable and as very useful. Most
patients rated that the contact made by NM health pro-
fessionals the day before the scan as being very appro-
priate (70.5%). That determines the importance of estab-
lishing an individualized relationship from the first time
[21, 27, 28].
Theway informationwas provided either before or during
18F-FDGPET/CT low dose scan is highly associated with sat-
isfaction of patients with NM Department. It has been indi-
cated by other studies inNMDepartments [3, 11, 13, 15, 27, 29]
that satisfaction is mainly influenced by the impression given
by the service organization and by the good performance
of professionals. Reyes-Pe´rez et al. [13] showed that patients
have a clear perception of health professionals and of the
quality of service, whether they are treated with dignity and
respect.
The data from our research also illustrate that although
patients are satisfied with NM Department and with the
quantity and quality of information that was given by the
staff, these aspects are not sufficient to reduce anxiety levels,
especially after 18F-FDG PET/CT low dose. Similar results
were found by Abreu et al. [15] with cancer patients and
by Carlson et al. [24] with women awaiting breast biopsy.
It seems that sensorial and procedural information that was
transmitted to cancer patients was adequate, but uncertain
outcomes have more influence on their distress than the
procedure itself. Therefore, health professionals also need to
focus on nonpharmacological strategies that allow patients’
to feel more reassurance during 18F-FDG PET/CT low dose
imaging [5, 8]. Bradley et al. [5] showed that improving
communication between patient and staff, through the use
of tangible devise, helps to lower anxiety levels in cancer
patients undergoing 18F-FDG PET/CT low dose scan. Vogel
et al. [8] proved that the use of audiovisual intervention
in the 18F-FDG PET/CT low dose uptake room allows
lowering patient anxiety, and Nightingale et al. [12] reach
the same conclusion with an introduction of environmental
distractions such as music in cardiac patients. These seem to
be effective strategies but require further evidence in larger
samples of cancer patients performing 18F-FDG PET/CT low
dose.
Abreu et al. [15] previously studied anxiety before and
after 18F-FDG PET/CT scan in oncological patients. How-
ever, considering participants and measurements, our study
adds some modifications that could explain the differences
of results in the two studies. In our sample, most patients
who underwent the scan had previous experience in PET/CT
scan, therefore already knowing the procedure. In the study
done by Abreu et al. [15], 71% of the patients underwent the
scan for the first time. The unfamiliarity could explain why
the patients feel more anxious before the PET/CT scan. The
measures of anxiety used in the two studies were different.
While Abreu et al. [15] used a thermometer, with a 10-point
Likert-type scale in which subjects were asked to rate their
feelings of anxiety, in our study, the anxiety was measured
using the STAI, a standardized anxiety questionnaire that
has been widely used in medical image procedures [8,
17, 19]. Despite the anxiety thermometer showing positive
correlation with the STAI results [30], our findings reinforce
the need for further investigation in this area. Considering
that, to the best of our knowledge, these are only two studies
that measure anxiety before and after a PET/CT scan; the
measurement of anxiety levels with thermometer and STAI
may prove useful in adding valuable insights of anxiety levels
experienced by oncological patients who undergo a PET/CT
scan.
This present study has some limitations. Although the
questionnaire used to evaluate patients’ 18F-FDG PET/CT
low dose experience had already been used in a previous
study, the survey hadnot been valuedwith regard to reliability
and validity. As far as the Scan Experience Questionnaire Pre
Scan is concerned, a few of the questions were answered by
less than 81 patients, yet the response rate was never under
80%; these missing data and the small number of patients
in total sample could also constrain the validity of this
study. Nevertheless, there are few studies concerning oncol-
ogy patients’ experience of anxiety undergoing 18F-FDG
PET/CT lowdose scan and therefore this study can contribute
further knowledge to improve patient management at NM
Department.
5. Conclusions
Cancer patients attending for 18F-FDG PET/CT low dose
are likely to experience levels of anxiety not only before the
scan but also after the scan. Concerns about scan results
were pointed out as the main factor for that emotional
reaction.
Health professionals at Nuclear Medicine Department
need to be aware of the patients’ levels of anxiety at all times,
even when there are no other signs of distress.
Although patients were satisfiedwith the information and
the care provided by NM’s team, findings suggest that, as far
as anxietymanagement is concerned, patients seem to require
support of professionals. Nonpharmacological techniques
that address uncertainty could be significant for patients
and need to be explored by nurses or/and NM’s technology
professionals.
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Appendix
Scan Experience Questionnaire (SEQ)













(4) Do you know the name of the scan you are going to
have?
◻ Yes
◻ No (If your answer is “no”, please go to
question 5)
If your answer is “yes”, please state the name below:
—
(5) Do you know why you are having this scan?
◻ Yes
◻ No (If your answer is “no”, please go to
question 6)
(5.1) If yes, please tick the reason why:
◻ Initial Staging
◻ Characterisation
◻ Assess response to treatment
◻ Exclude recurrence
◻ Other —
(6) Is this the first time you are having this scan done?
◻ Yes
◻ No (If your answer is “no” please go to
question 8)






(8) Considered your scan appointment,
(8.1) How would you rate the information provided
to you in terms of understanding?
Please mark the side of the scale that most
reflects your opinion with a cross (X)
Incomprehensible Completely 
understandable
(8.2) How would you rate the information provided
to you in terms of helpfulness?
Please mark the side of the scale that most
reflects your opinion with a cross (X)
Useless Very useful
Post Scan Experience Questionnaire (SEQ Post Scan)






(2) How would you rate the scan procedure?
Difficult 1 2 3 4 5 Easy
Negative experience 1 2 3 4 5 Good
Experience
(3) How would you describe the scan that you have just
had done?
Uncomfortable 1 2 3 4 5 Comfortable
Weary 1 2 3 4 5 Tolerable
Not in control 1 2 3 4 5 In control
Claustrophobic 1 2 3 4 5 Not claus-
trophobic
Information
(4) How would you rate the information you were pro-
vided with in terms of:
(4.1) Comprehension: Please mark the side of the




(4.2) Helpfulness: Please mark the side of the scale
that most reflects your opinion with a cross (X)
Useless Very useful
8 Nursing Research and Practice
(5) How would you rate the answers given to you by the
staff?
Please mark the side of the scale that most
reflects your opinion with a cross (X)
Inadequate Very adequate
Service
(6) Do you believe the staff treated you with dignity and
respect during your timewithin theNuclearMedicine
service?
Please mark the side of the scale that most
reflects your opinion with a cross (X)
No, never Yes, always
(7) As a whole, how satisfied are you with the PET
department?
Please mark the side of the scale that most
reflects your opinion with a cross (X)
Very unsatisfied Very satisfied
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